• Info
  • Significant Ownership

Significant Ownership of J. WOOD CAPITAL ADVISORS LLC

Signature - Title
/s/ Jason Wood - Jason Wood, Chief Executive Officer
Location
Santa Rosa, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by J. WOOD CAPITAL ADVISORS LLC.

Notify me when J. WOOD CAPITAL ADVISORS LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of J. WOOD CAPITAL ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CYCN Cyclerion Therapeutics, Inc. Common Stock, no par value 5.4% $496,363 181,818 J. Wood Capital Advisors LLC 25 Mar 2025
KPTI Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value 5% $6,546,231 1,000,708 J. Wood Capital Advisors LLC 14 Oct 2025

Schedules 13D/G Reported by J. WOOD CAPITAL ADVISORS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.